✦ LIBER ✦

Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition

✍ Scribed by Burtness, Barbara; Bauman, Julie E; Galloway, Thomas

Book ID: 121448317
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 964 KB
Volume: 14
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(13)70085-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting EGFR resistance networks in he

Targeting EGFR resistance networks in head and neck cancer

✍ Vladimir Ratushny; Igor Astsaturov; Barbara A. Burtness; Erica A. Golemis; Joshu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 653 KB

Overcoming resistance to EGFR inhibitor

Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature

✍ Guilherme Rabinowits; Robert I. Haddad 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Beyond Cetuximab for Head and Neck Cance

Beyond Cetuximab for Head and Neck Cancer: Dual Target Antibody Blockade of EGFR and HER3 Enhances Radiosensitivity and Overcomes Acquired Resistance to EGFR Inhibitors

✍ P.M. Harari; S. Huang; C. Li; M.X. Sliwkowski 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Mechanisms of resistance to EGFR inhibit

Mechanisms of resistance to EGFR inhibitors in head and neck cancer

✍ Jonathan B. Cooper; Ezra Eddy Wyssam Cohen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that activates multiple signaling pathways, including phosphatidylinositol‐3‐kinase/v‐AKT murine thymoma viral oncogene homolog protein (Akt), has long been a target of novel therapies. Despite universal EGFR expression

PD23 Targeting apoptosis to overcome cis

PD23 Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer

✍ Bauer, J.A.; Kumar, B.; Cordel, K.G.; Lee, J.S.; Prince, M.E.; Tran, H.H.; Wolf, 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 59 KB

Mutant Epidermal Growth Factor Receptor

Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

✍ Sok, J. C. 📂 Article 📅 2006 🏛 American Association for Cancer Research 🌐 English ⚖ 552 KB